A carregar...
Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
Atorvastatin and direct oral factor Xa inhibitors (xabans) are frequently co‐administrated in patients with atrial fibrillation (AF). However, no studies investigating the possibility of the pharmacologic interaction between these agents have been conducted. The aim of this prospective observational...
Na minha lista:
| Publicado no: | Pharmacol Res Perspect |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8118196/ https://ncbi.nlm.nih.gov/pubmed/33984191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.730 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|